Press release
The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2020-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:
A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.
A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.
Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.
An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines.
An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus infection.
An analysis of the investments made in this domain, during the period between 2015 and 2020 (till March).
A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Route of Administration
Intramuscular
Subcutaneous
Oral
Intravenous
Others
Type of Vaccine
Pneumococcal Conjugate Vaccine
Human Papilloma Virus Vaccine
Rotavirus Vaccine
Influenza Vaccine
MMR Vaccine
Tetanus and Diphtheria Booster Vaccine
Varicella Vaccine
DTaP-Hib-IPV Vaccine
DTaP-HepB-Hib-IPV Vaccine
Others
Type of Vaccine API
Live, Attenuated Vaccine
Inactivated Vaccine
Conjugate Vaccine
Subunit Vaccine
Toxoid Vaccine
Others
Target Patient Population
Pediatric Patients
Adults
Key Players
GlaxoSmithKline
Merck
Sanofi Pasteur
Pfizer
Emergent BioSolutions
CSL
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Rest of the World
Key companies covered in the report
Bio Farma
Emergent BioSolutions
GC Pharma
GlaxoSmithKline
Janssen
Merck
Novavax
Pfizer
Sanofi Pasteur
Valneva
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
Other Recent Offerings
- Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
- Novel Vaccine Delivery Devices Market, 2019-2030 [COVID-19 SERIES]
- Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030 [COVID-19 SERIES]
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis here
News-ID: 2228564 • Views: …
More Releases from Roots Analysis
Electronic Health Records Market to Reach $92 Billion by 2035, Growing at 8.3% C …
The global electronic health records market, valued at USD 41 billion in 2025, will reach USD 45 billion in 2026 and is on track to hit USD 92 billion by 2035, compounding at 8.3% annually over the 2026-to-2035 forecast period, according to new research published by Roots Analysis. The growth is being driven by a converging set of forces: surging demand for efficient healthcare data management, government mandates accelerating digital…
Thermoplastic Elastomers Market to Reach $47.25 Billion by 2035 at 5.30% CAGR | …
The global thermoplastic elastomers market, valued at USD 26.77 billion in 2024, will grow to USD 47.25 billion by 2035, advancing at a compound annual growth rate of 5.30% over the forecast period. Demand is accelerating across automotive, medical, and electrical sectors as manufacturers seek materials that combine the flexibility of rubber with the processing advantages of thermoplastics. The convergence of electric vehicle adoption, aging population dynamics, and the shift…
Healthcare Cybersecurity Market to Reach $115 Billion by 2035, Growing at 17.0% …
The global healthcare cybersecurity market, valued at USD 24 billion in 2025, is on course to reach USD 115 billion by 2035, expanding at a compound annual growth rate of 17.0% over the forecast period. Surging ransomware attacks, the rapid digitization of clinical infrastructure, and tightening regulatory mandates are together creating one of the most urgent investment cases in the healthcare technology sector. Organizations that delay action face mounting financial…
In Vitro Diagnostics Market to Reach $190 Billion by 2035, Growing at 4.9% CAGR …
The global in vitro diagnostics market, valued at USD 113 billion in 2025, is projected to reach USD 118 billion in 2026 and climb to USD 190 billion by 2035, advancing at a compound annual growth rate of 4.9% over the forecast period. Rising chronic disease rates, accelerating adoption of point-of-care testing, and growing healthcare expenditure across both developed and emerging economies are converging to make IVD one of the…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Flu Vaccine (Influenza Vaccine) Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Flu Vaccine (Influenza Vaccine) Market Breakdown by Application (For Children (6 months to 3 years), For Adults and Children over 3 years) by Type (Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines, Live Attenuated Virus Vaccines) and by Geography (North America, South…
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
